See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2012

Cell Delivery Strategies for Chronic Pulmonary Disease

Presenter: Amit Patel

January 25, 2012

Presentation Cell Therapy 2012

The AMICI Trial

Presenter: Henricus J. Duckers

January 25, 2012

Presentation

Association of PPI Use and Cardiovascular Outcomes with Clopidogrel and Ticagrelor

Presenter: Shaun G. Goodman

January 24, 2012

Presentation

Ensayo Aleatorizado Multicentro Comparador de Amfilimus con Stents Liberadores de Paclitaxel en Lesiones Coronarias Nativas De Novo

Presenter: Didier Carri?

January 24, 2012

Presentation Cell Therapy 2012

Regulating Cardiac Signaling for Therapeutic Gain

Presenter: Martiza Mayorga

January 24, 2012

Presentation Cell Therapy 2012

Biomanipulation of Left Ventricular Wall Stress with a Novel Therapeutic Device: Assessment of Changes

Presenter: Randall J. Lee

January 24, 2012

Presentation Cell Therapy 2012

Rescuing from Smoke-Induced Pathology: Moving from Adipose-Derived Stem Cells to Their Secretome

Presenter: Keith L. March

January 24, 2012

Presentation Cell Therapy 2012

Bioengineering Platforms for Stem Cell Delivery

Presenter: Gordana Vunjak-Novakovic

January 24, 2012

Presentation Cell Therapy 2012

New, Potent, and Safe Source of Human MSCs: From Human Embryonic Stem Cells

Presenter: Hyo-Soo Kim

January 24, 2012

Presentation

A Multicenter Randomized Trial Comparing Amphilimus- With Paclitaxel-Eluting Stents in De Novo Native Coronary Artery Lesions

Presenter: Didier Carrie

January 24, 2012

Advertisement

Slides

Cell Delivery Strategies for Chronic Pulmonary Disease

The AMICI Trial

Association of PPI Use and Cardiovascular Outcomes with Clopidogrel and Ticagrelor

Ensayo Aleatorizado Multicentro Comparador de Amfilimus con Stents Liberadores de Paclitaxel en Lesiones Coronarias Nativas De Novo

Regulating Cardiac Signaling for Therapeutic Gain

Biomanipulation of Left Ventricular Wall Stress with a Novel Therapeutic Device: Assessment of Changes

Rescuing from Smoke-Induced Pathology: Moving from Adipose-Derived Stem Cells to Their Secretome

Bioengineering Platforms for Stem Cell Delivery

New, Potent, and Safe Source of Human MSCs: From Human Embryonic Stem Cells

A Multicenter Randomized Trial Comparing Amphilimus- With Paclitaxel-Eluting Stents in De Novo Native Coronary Artery Lesions

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content